SaltX Technology Holding B Logo

SaltX Technology Holding B

Develops electric calcination tech to decarbonize heavy industries like cement and capture CO2.

SALT | ST

Overview

Corporate Details

ISIN(s):
SE0005308541 (+1 more)
LEI:
549300W31010S0FY9U64
Country:
Sweden
Address:
Västertorpsvägen 135, 129 44 Hägersten
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

SaltX Technology is a greentech company dedicated to decarbonizing heavy industries and eliminating their dependency on fossil fuels. The company innovates and industrializes electrification and carbon separation technologies targeting hard-to-abate sectors like cement and quicklime. Its core technology is the Electric Arc Calciner (EAC), a proprietary electric calcination process that replaces fossil-fuel heating. The EAC technology simultaneously separates and captures process-related CO2 emissions, creating a pathway to zero-emission manufacturing. SaltX collaborates with major industrial partners, such as Holcim and SMA Mineral, to scale its solutions and achieve gigaton-level impact on global emissions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all SaltX Technology Holding B filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SaltX Technology Holding B

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SaltX Technology Holding B via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Pasithea Therapeutics Corp. Logo
Developing innovative therapeutics for CNS disorders (ALS, MS) and RASopathies.
United States of America
KTTA
Passage BIO, Inc. Logo
Developing genetic medicines for severe CNS and neurodegenerative disorders.
United States of America
PASG
PAVmed Inc. Logo
A med-tech firm offering diagnostics for esophageal precancer & digital health for cancer care.
United States of America
PAVM
PepGen Inc. Logo
Biotech using an EDO platform to treat genetic neuromuscular & neurological diseases.
United States of America
PEPG
Perseus Proteomics Inc. Logo
Develops antibody drugs for cancer, provides research support, and sells diagnostic reagents.
Japan
4882
PExA AB Logo
Offers non-invasive lung liquid biopsy tech for respiratory disease research.
Sweden
PEXA B
Pharos iBio Co., Ltd. Logo
AI-powered drug development for rare and refractory diseases, focusing on oncology.
South Korea
388870
Pherecydes Pharma Logo
Develops precision phage therapy to treat resistant bacterial infections.
France
ALPHE
PhoenixBio Co.,Ltd. Logo
CRO providing humanized liver mouse models and testing services for preclinical drug development.
Japan
6190
PILA PHARMA AB Logo
Clinical-stage biopharma developing a first-in-class oral drug for diabetes and obesity.
Sweden
PILA

Talk to a Data Expert

Have a question? We'll get back to you promptly.